Medical Writers News Hubb
Advertisement Banner
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
  • Home
  • News
  • Papers
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home News

Spartech hires Bosch VP Dan Gallo as chief operating officer

admin by admin
September 28, 2022
in News


Dan Gallo is the chief operating officer at Spartech. [Photo courtesy of Spartech]

Spartech today said it hired Dan Gallo as chief operating officer of the engineered thermoplastics and custom packaging manufacturer.

Gallo started this month, according to his LinkedIn page. His career leading operations, supply chain and logistics functions spans more than three decades. He was most recently an operations VP at Robert Bosch.

Before his time at Bosch, Gallo was senior plant manager for Spartech’s Muncie, Indiana location and later served as the company’s director of manufacturing.

Gallo will be responsible for all of St. Louis, Missouri-based Spartech’s 17 manufacturing facilities except for the Sherman Plastics location in Naperville, Illinois. He will focus on driving excellence across safety, quality, service and productivity initiatives while fostering strong collaboration with commercial, business management and innovation to accelerate growth, the company said.

“Dan’s leadership will be integral in our development and enhancement of a ONE Spartech culture,” Spartech CEO John Inks said in a news release. “He will play a major role in helping us improve our speed to deliver customer excellence and leverage all of our core values.”

Inks was chief operating officer until he became CEO in October 2020. Spartech welcomed another new executive to the C-suite in May with the hiring of Marshall Scott as CFO.

Spartech is owned by private equity firm The Jordan Co. and Spartech’s management, following several ownership changes in recent years.

PolyOne purchased the company for $393 million in 2012 and closed at least six of its 30 plants. PolyOne sold the business — known as its Designed Structures and Solutions (DSS) segment — to private equity firm Arsenal Capital Partners for $115 million in 2017.

Arsenal sold Spartech to another private equity firm, Nautic Partners, in 2019. Nautic retained a minority stake when it sold Spartech to The Jordan Co. in 2021.



Source link

Previous Post

Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells models

Next Post

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Next Post

Researchers to use $1 million grant for improving blood cancer diagnosis and treatment

Recommended

J&J MedTech names Ahmet Tezel as innovation and R&D head

5 months ago

Expert panel identifies critical challenges in recruiting study participants

8 months ago

4 ways to usher in next-gen medical device design

5 months ago

Researchers develop a lateral flow test to reliably identify and quantify allergens in foods

3 months ago

How to attract, engage and retain medtech manufacturing talent

2 months ago

Spinal cord stimulation helps with mobility after stroke

1 month ago
Medical-Writers-(-white-)

© Medical Writers News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Papers
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Papers
  • Contact

© 2022 Medical Writers News Hubb All rights reserved.